1. MicroRNAs in Breast Cancer and Their Value as Biomarkers
   Olafur Andri Stefansson, 2016, Epigenetic Biomarkers and Diagnostics CrossRef
2. Effects of miR-155 Antisense Oligonucleotide on Breast Carcinoma Cell Line MDA-MB-157 and Implanted Tumors
   Shu-Rong Zheng et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef
3. The Clinicopathological Significance of MicroRNA-155 in Breast Cancer: A Meta-Analysis
   Hui Zeng et al, 2014, BioMed Research International CrossRef
4. miR-homoHSV of Singapore Grouper Iridovirus (SGIV) Inhibits Expression of the SGIV Pro-apoptotic Factor LITAF and Attenuates Cell Death
   Chuanyu Guo et al, 2013, PLoS ONE CrossRef
5. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
   Raquel Nogueras Pérez et al, 2023, International Journal of Molecular Sciences CrossRef
6. MicroRNA-155 complementation on a chemically functionalized dual electrode surface for determining breast cancer
   Subash C. B. Gopinath et al, 2020, 3 Biotech CrossRef
7. miR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis
   Nina Petrović et al, 2016, Cancer Biomarkers CrossRef
8. The rs767649 polymorphism in the promoter of miR-155 contributes to the decreased risk for cervical cancer in a Chinese population
   Shizhi Wang et al, 2016, Gene CrossRef
9. High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation
   Guizhi Dong et al, 2014, Medical Oncology CrossRef
10. Potential Biomarker Panels in Overall Breast Cancer Management: Advancements by Multilevel Diagnostics
    Shantanu Girotra et al, 2016, Personalized Medicine CrossRef
11. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206
    Kai Xue et al, 2019, Life Sciences CrossRef
12. Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
    Anna Maria Grimaldi et al, 2020, International Journal of Molecular Sciences CrossRef
13. Clinical Evaluation of the Diagnostic Role of MicroRNA-155 in Breast Cancer
    Fatemeh Hosseini Mojahed et al, 2020, International Journal of Genomics CrossRef
14. Prognostic Implications of microRNA-155, -133a, -21 and -205 in Breast Cancer Patients’ Plasma
    Aarthy Raghu et al, 2021, MicroRNA CrossRef
15. Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity
    Thomas B. Huffaker et al, 2012, Cell Reports CrossRef
16. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance
    Abbas Navabi et al, 2022, Life Sciences CrossRef
17. Non-Coding RNAs Regulate Spinal Cord Injury-Related Neuropathic Pain via Neuroinflammation
    Jing Zhu et al, 2023, Journal of Inflammation Research CrossRef
18. MiR-155-5p and MiR-203a-3p Are Prognostic Factors in Soft Tissue Sarcoma
    Thomas Greither et al, 2020, Cancers CrossRef
19. Expression and function ofmiR-155 in breast cancer
    Jing Liu et al, 2015, Biotechnology & Biotechnological Equipment CrossRef
20. Expression of micrornas in molecular genetic breast cancer subtypes
    N.N. Kolesnikov et al, 2019, Cancer Treatment and Research Communications CrossRef